The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 4,160,250 | 225,000 | SH | SOLE | 225,000 | 0 | 0 | |||
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 3,698,000 | 200,000 | SH | Call | SOLE | 200,000 | 0 | 0 | ||
AEROVATE THERAPEUTICS INC | COM | 008064107 | 6,653,250 | 225,000 | SH | SOLE | 225,000 | 0 | 0 | |||
ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 8,967,000 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | |||
ALTIMMUNE INC | COM NEW | 02155H200 | 2,545,000 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | |||
AN2 THERAPEUTICS INC | COM | 037326105 | 712,826 | 219,331 | SH | SOLE | 219,331 | 0 | 0 | |||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 7,641,400 | 130,000 | SH | SOLE | 130,000 | 0 | 0 | |||
AQUESTIVE THERAPEUTICS INC | COM | 03843E104 | 2,994,529 | 702,941 | SH | SOLE | 702,941 | 0 | 0 | |||
ARROWHEAD PHARMACEUTICALS IN | COM | 04280A100 | 1,001,000 | 35,000 | SH | SOLE | 35,000 | 0 | 0 | |||
ARVINAS INC | COM | 04335A105 | 1,651,200 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | |||
ASTRIA THERAPEUTICS INC | COM | 04635X102 | 1,618,625 | 115,000 | SH | SOLE | 115,000 | 0 | 0 | |||
ATYR PHARMA INC | COM NEW | 002120202 | 1,170,000 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | |||
AXSOME THERAPEUTICS INC | COM | 05464T104 | 16,758,000 | 210,000 | SH | SOLE | 210,000 | 0 | 0 | |||
BIOHAVEN LTD | COM | G1110E107 | 15,586,650 | 285,000 | SH | SOLE | 285,000 | 0 | 0 | |||
BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 6,902,108 | 72,761 | SH | SOLE | 72,761 | 0 | 0 | |||
BRIDGEBIO PHARMA INC | COM | 10806X102 | 5,411,000 | 175,000 | SH | SOLE | 175,000 | 0 | 0 | |||
CABALETTA BIO INC | COM | 12674W109 | 6,397,500 | 375,000 | SH | SOLE | 375,000 | 0 | 0 | |||
CG ONCOLOGY INC | COM | 156944100 | 3,292,500 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | |||
COGENT BIOSCIENCES INC | COM | 19240Q201 | 3,024,000 | 450,000 | SH | SOLE | 450,000 | 0 | 0 | |||
CORBUS PHARMACEUTICALS HLDGS | COM NEW | 21833P301 | 2,234,365 | 56,941 | SH | SOLE | 56,941 | 0 | 0 | |||
CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | 9,362,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | |||
CYTOKINETICS INC | COM NEW | 23282W605 | 1,402,200 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | |||
CYTOKINETICS INC | COM NEW | 23282W605 | 5,258,250 | 75,000 | SH | Call | SOLE | 75,000 | 0 | 0 | ||
CYTOMX THERAPEUTICS INC | COM | 23284F105 | 1,308,000 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | |||
DECIPHERA PHARMACEUTICALS IN | COM | 24344T101 | 2,776,549 | 176,513 | SH | SOLE | 176,513 | 0 | 0 | |||
ELEVATION ONCOLOGY INC | COM | 28623U101 | 1,282,500 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | |||
ENGENE HOLDINGS INC | COM | 29286M105 | 3,390,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | |||
EYEPOINT PHARMACEUTICALS INC | COM NEW | 30233G209 | 1,860,300 | 90,000 | SH | SOLE | 90,000 | 0 | 0 | |||
GERON CORP | COM | 374163103 | 2,640,000 | 800,000 | SH | SOLE | 800,000 | 0 | 0 | |||
HELIX ACQUISITION CORP II | CL A ORD SHS | G4444H101 | 3,120,000 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | |||
IMMUNOVANT INC | COM | 45258J102 | 4,038,750 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | |||
IMMUNOVANT INC | COM | 45258J102 | 4,846,500 | 150,000 | SH | Call | SOLE | 150,000 | 0 | 0 | ||
INSMED INC | COM PAR $.01 | 457669307 | 4,069,500 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | |||
INTELLIA THERAPEUTICS INC | COM | 45826J105 | 687,750 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | |||
INTRA-CELLULAR THERAPIES INC | COM | 46116X101 | 3,460,000 | 50,000 | SH | Call | SOLE | 50,000 | 0 | 0 | ||
KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 2,372,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | |||
KRYSTAL BIOTECH INC | COM | 501147102 | 2,491,020 | 14,000 | SH | SOLE | 14,000 | 0 | 0 | |||
LARIMAR THERAPEUTICS INC | COM | 517125100 | 1,598,477 | 210,603 | SH | SOLE | 210,603 | 0 | 0 | |||
MADRIGAL PHARMACEUTICALS INC | COM | 558868105 | 1,735,760 | 6,500 | SH | SOLE | 6,500 | 0 | 0 | |||
MARINUS PHARMACEUTICALS INC | COM NEW | 56854Q200 | 2,576,400 | 285,000 | SH | SOLE | 285,000 | 0 | 0 | |||
MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | 61559X104 | 15,069,000 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | |||
NATERA INC | COM | 632307104 | 2,286,500 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | |||
NEUROGENE INC | COM | 64135M105 | 1,272,500 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | |||
OLEMA PHARMACEUTICALS INC | COM | 68062P106 | 2,264,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | |||
PERSPECTIVE THERAPEUTICS INC | COM | 46489V104 | 7,140,000 | 6,000,000 | SH | SOLE | 6,000,000 | 0 | 0 | |||
PHATHOM PHARMACEUTICALS INC | COM | 71722W107 | 5,150,700 | 485,000 | SH | SOLE | 485,000 | 0 | 0 | |||
PMV PHARMACEUTICALS INC | COM | 69353Y103 | 1,147,500 | 675,000 | SH | SOLE | 675,000 | 0 | 0 | |||
PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 2,169,750 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | |||
RAPT THERAPEUTICS INC | COM | 75382E109 | 2,694,000 | 300,000 | SH | Call | SOLE | 300,000 | 0 | 0 | ||
REGENXBIO INC | COM | 75901B107 | 2,528,400 | 120,000 | SH | SOLE | 120,000 | 0 | 0 | |||
REPLIMUNE GROUP INC | COM | 76029N106 | 5,310,500 | 650,000 | SH | SOLE | 650,000 | 0 | 0 | |||
REVANCE THERAPEUTICS INC | COM | 761330109 | 2,214,000 | 450,000 | SH | SOLE | 450,000 | 0 | 0 | |||
RHYTHM PHARMACEUTICALS INC | COM | 76243J105 | 5,416,250 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | |||
ROIVANT SCIENCES LTD | SHS | G76279101 | 13,702,000 | 1,300,000 | SH | SOLE | 1,300,000 | 0 | 0 | |||
SAGIMET BIOSCIENCES INC | COM SER A | 786700104 | 1,219,500 | 225,000 | SH | SOLE | 225,000 | 0 | 0 | |||
SAREPTA THERAPEUTICS INC | COM | 803607100 | 16,182,500 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | |||
SAVARA INC | COM | 805111101 | 7,968,000 | 1,600,000 | SH | SOLE | 1,600,000 | 0 | 0 | |||
SOLENO THERAPEUTICS INC | COM | 834203309 | 8,560,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | |||
SPDR SER TR | S&P BIOTECH | 78464A870 | 23,722,500 | 250,000 | SH | Put | SOLE | 250,000 | 0 | 0 | ||
SPYRE THERAPEUTICS INC | COM NEW | 00773J202 | 3,793,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | |||
STRUCTURE THERAPEUTICS INC | SPONSORED ADS | 86366E106 | 3,214,500 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | |||
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 3,570,000 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | |||
TARSUS PHARMACEUTICALS INC | COM | 87650L103 | 10,905,000 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | |||
TAYSHA GENE THERAPIES INC | COM SHS | 877619106 | 2,726,500 | 950,000 | SH | SOLE | 950,000 | 0 | 0 | |||
TENAYA THERAPEUTICS INC | COM | 87990A106 | 4,053,250 | 775,000 | SH | SOLE | 775,000 | 0 | 0 | |||
TG THERAPEUTICS INC | COM | 88322Q108 | 12,548,250 | 825,000 | SH | SOLE | 825,000 | 0 | 0 | |||
ULTRAGENYX PHARMACEUTICAL IN | COM | 90400D108 | 933,800 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | |||
UNIQURE NV | SHS | N90064101 | 858,000 | 165,000 | SH | SOLE | 165,000 | 0 | 0 | |||
VAXCYTE INC | COM | 92243G108 | 6,489,450 | 95,000 | SH | SOLE | 95,000 | 0 | 0 | |||
VIKING THERAPEUTICS INC | COM | 92686J106 | 5,986,164 | 73,002 | SH | SOLE | 73,002 | 0 | 0 | |||
VIKING THERAPEUTICS INC | COM | 92686J106 | 6,560,000 | 80,000 | SH | Call | SOLE | 80,000 | 0 | 0 | ||
VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 10,943,750 | 625,000 | SH | SOLE | 625,000 | 0 | 0 |